Please login to the form below

Not currently logged in

Victor Bulto

This page shows the latest Victor Bulto news and features for those working in and with pharma, biotech and healthcare.

Novartis’ Kymriah receives FDA approval to treat follicular lymphoma

Novartis’ Kymriah receives FDA approval to treat follicular lymphoma

treatment for patients with follicular lymphoma,” said Victor Bulto, president, Novartis Innovative Medicines US.

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....